Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing
Back

Rohit Chandwani, MD, PhD (he/him/his)

Attending
Weill Cornell Medical College
New York, New York, United States

Rohit Chandwani, M.D., Ph.D. is an Assistant Professor in the Division of Liver Transplantation, Hepatobiliary and Pancreatic Surgery in the Department of Surgery and in the Department of Cell and Developmental Biology at Weill Cornell Medicine. He is also the Mildred F. and John L. Rasweiler Scholar in Cancer Research in the Meyer Cancer Center at Cornell.

Dr. Chandwani received his undergraduate degree in Economics from Harvard University and earned his medical degree at the Yale University School of Medicine. He then trained in General Surgery at Columbia University Medical Center and in Surgical Oncology at Memorial Sloan Kettering Cancer Center, where he was Chief Fellow for the Department of Surgery. His clinical practice at Weill Cornell Medicine focuses on the surgical treatment of pancreatic and liver disease, with a significant focus on novel therapeutic approaches to pancreatic cancer.

A surgeon-scientist, Dr. Chandwani is also Principal Investigator of the Laboratory of Cancer Epigenetics, where he studies the epigenetic dysregulation underlying inflammation, tumor initiation, and cancer progression. His laboratory is known for the application of chromatin-based tools to interrogate cell fate in pancreatic development, cell fate decisions, tumorigenesis, and malignant progression. Dr. Chandwani earned his Ph.D. from The Rockefeller University in the laboratory of Alexander Tarakhovsky and was a postdoctoral fellow in the laboratory of Steven D. Leach at MSKCC. He has been the recipient of funding from the National Cancer Institute (NCI), the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), the American Association for Cancer Research (AACR), the Emerson Collective Cancer Research Fund, the American Surgical Association, and the Pancreatic Cancer Action Network for his work in cancer epigenetics.

Presentation(s):